Gottlieb Joins HHS Transition Team; Will Next Stop Be FDA?
Former US FDA, CMS official has been among those thought to be in the running for Trump's FDA commissioner nomination.
You may also be interested in...
As FDA Commissioner Robert Califf prepares to step down from his post to make way for a Trump administration replacement, former Acting Commissioner Stephen Ostroff may step into the breach.
The Trump transition team is considering Jim O'Neill, a Silicon Valley investment manager, to head US FDA, according to news reports. Previous comments from O'Neill – who has some HHS experience – suggest, he favors substantially reducing FDA's role in assessing product effectiveness. While some experts are highly skeptical about O'Neill, others suggest he could champion much-needed change at the agency.
With HHS and CMS leaders nominated, President-elect Trump’s team now may move to US FDA evaluation, commissioner candidates.